[Elsevier] Intermediate-dose immune tolerance induction outperforms with faster success, less bleeding, and no added cost in comparison with low dose: a multicenter randomized clinical trial

jirawan Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-06-16 02:04
Reward10points

journalㄩResearch and Practice in Thrombosis and Haemostasis

AuthorsㄩZhengping Li; Zekun Li; Xiaoling Cheng; Heng Zhang; Can Yang; Qian Xu; Zhenping Chen; Yingzi Zhen; Gang Li; Guoqing Liu; Wanru Yao; Min Zhou; Jiao Jin; Jie Huang; Yongjun Fang; Liangzhi Xie; Man-Chiu Poon; Runhui Wu

Published dateㄩ2025-1-

DOIㄩ10.1016/j.rpth.2024.102639

PDF linkㄩhttps://www.sciencedirect.com/sc ... 475037924003340/pdf

Article linkㄩhttps://doi.org/10.1016/j.rpth.2024.102639

Article SourceㄩElsevier BV


Remarkㄩ
Reply

Use magic Donate Report

All Reply2 Show all posts
doc.researcher Post time 24 min. ago | Show all posts

Waiting for confirmation

If the PDF has not been accepted after 72 hours, the system will automatically adopt it.
Reply

Use magic Donate Report

doc.researcher Post time 23 min. ago | Show all posts

Waiting for confirmation

If the PDF has not been accepted after 72 hours, the system will automatically adopt it.
Reply

Use magic Donate Report

Intermediate member
  • post

  • reply

  • points

    470


Daily Top Contributors

Return to the list